Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction

被引:27
作者
Crooks, Ema T. [1 ]
Osawa, Keiko [1 ]
Tong, Tommy [1 ,7 ]
Grimley, Samantha L. [1 ]
Dai, Yang D. [2 ]
Whalen, Robert G. [5 ]
Kulp, Daniel W. [3 ,4 ]
Menis, Sergey [3 ,4 ]
Schief, William R. [3 ,4 ,6 ]
Binley, James M. [1 ]
机构
[1] San Diego Biomed Res Inst, 10865 Rd Cure, San Diego, CA 92121 USA
[2] Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[5] Altravax Inc, 725 San Aleso Ave,Suite 2, Sunnyvale, CA 94085 USA
[6] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA
[7] Sunway Univ, Sch Sci & Technol, Dept Biol Sci, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia
关键词
HIV-1; Env; trimer; Gp120; neutralization; Vaccine; VLP; Antibody; Glycan; VIRUS-LIKE PARTICLES; PROXIMAL EXTERNAL REGION; B-CELL RECEPTORS; MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZATION; BROAD NEUTRALIZATION; MATURATION PATHWAY; IMMUNOGEN DESIGN; GP120; GERMLINE;
D O I
10.1016/j.virol.2017.02.024
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously, VLPs bearing JR-FL strain HIV-1 Envelope trimers elicited potent neutralizing antibodies (nAbs) in 2/8 rabbits (PLoS Pathog 11(5): e1004932) by taking advantage of a naturally absent glycan at position 197 that borders the CD4 binding site (CD4bs). In new immunizations, we attempted to improve nAb responses by removing the N362 glycan that also lines the CD4bs. All 4 rabbits developed nAbs. One targeted the N197 glycan hole like our previous sera. Two sera depended on the N463 glycan, again suggesting CD4bs overlap. Heterologous boosts appeared to reduce nAb clashes with the N362 glycan. The fourth serum targeted a N362 glycan-sensitive epitope. VLP manufacture challenges prevented us from immunizing larger rabbit numbers to empower a robust statistical analysis. Nevertheless, trends suggest that targeted glycan removal may improve nAb induction by exposing new epitopes and that it may be possible to modify nAb specificity using rational heterologous boosts.
引用
收藏
页码:193 / 209
页数:17
相关论文
共 88 条
[1]   The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle [J].
Abrahamyan, LG ;
Mkrtchyan, SR ;
Binley, J ;
Lu, M ;
Melikyan, GB ;
Cohen, FS .
JOURNAL OF VIROLOGY, 2005, 79 (01) :106-115
[2]   Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer [J].
Alsahafi, Nirmin ;
Debbeche, Olfa ;
Sodroski, Joseph ;
Finzi, Andres .
PLOS ONE, 2015, 10 (04)
[3]   4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues [J].
Alving, Carl R. .
AIDS, 2008, 22 (05) :649-651
[4]  
Bashratyan R., 2017, EUR J IMMUNOL
[5]   Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein [J].
Behrens, Anna-Janina ;
Vasiljevic, Snezana ;
Pritchard, Laura K. ;
Harvey, David J. ;
Andev, Rajinder S. ;
Krumm, Stefanie A. ;
Struwe, Weston B. ;
Cupo, Albert ;
Kumar, Abhinav ;
Zitzmann, Nicole ;
Seabright, Gemma E. ;
Kramer, Holger B. ;
Spencer, Daniel I. R. ;
Royle, Louise ;
Lee, Jeong Hyun ;
Klasse, Per J. ;
Burton, Dennis R. ;
Wilson, Ian A. ;
Ward, Andrew B. ;
Sanders, Rogier W. ;
Moore, John P. ;
Doores, Katie J. ;
Crispin, Max .
CELL REPORTS, 2016, 14 (11) :2695-2706
[6]   Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies [J].
Bhiman, Jinal N. ;
Anthony, Colin ;
Doria-Rose, Nicole A. ;
Karimanzira, Owen ;
Schramm, Chaim A. ;
Khoza, Thandeka ;
Kitchin, Dale ;
Botha, Gordon ;
Gorman, Jason ;
Garrett, Nigel J. ;
Karim, Salim S. Abdool ;
Shapiro, Lawrence ;
Williamson, Carolyn ;
Kwong, Peter D. ;
Mascola, John R. ;
Morris, Lynn ;
Moore, Penny L. .
NATURE MEDICINE, 2015, 21 (11) :1332-1336
[7]   Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization [J].
Binley, James M. ;
Ban, Yih-En Andrew ;
Crooks, Emma T. ;
Eggink, Dirk ;
Osawa, Keiko ;
Schief, William R. ;
Sanders, Rogier W. .
JOURNAL OF VIROLOGY, 2010, 84 (11) :5637-5655
[8]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[9]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643
[10]   Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41 [J].
Blish, Catherine A. ;
Nguyen, Minh-An ;
Overbaugh, Julie .
PLOS MEDICINE, 2008, 5 (01) :90-103